Jpmorgan Chase & CO Bausch & Lomb Corp Transaction History
Jpmorgan Chase & CO
- $1.51 Trillion
- Q3 2025
A detailed history of Jpmorgan Chase & CO transactions in Bausch & Lomb Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 83 shares of BLCO stock, worth $1,294. This represents 0.0% of its overall portfolio holdings.
Number of Shares
83
Previous 83
-0.0%
Holding current value
$1,294
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BLCO
# of Institutions
104Shares Held
35.1MCall Options Held
375KPut Options Held
255K-
Deutsche Bank Ag\ Frankfurt Am Main, 2M3.5MShares$54.6 Million0.02% of portfolio
-
Icahn Carl C Sunny Isles Beach, FL3.5MShares$54.6 Million0.59% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca3.25MShares$50.6 Million1.24% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.61MShares$40.7 Million0.03% of portfolio
-
Silver Point Capital L.P. Greenwich, CT2.57MShares$40 Million2.87% of portfolio
About Bausch & Lomb Corp
- Ticker BLCO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 350,000,000
- Market Cap $5.46B
- Description
- Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replace...